Flagship Pioneering-founded Valo Health has announced the appointment of Dr Brian Alexander as its new CEO.
Additionally, Alexander will serve as Flagship Pioneering’s CEO-partner.
With 20 years of experience in biotechnology and medical leadership, he aims to enhance Valo Health’s mission to accelerate drug discovery and development.
Alexander said: “I am deeply honoured to join Flagship Pioneering and Valo Health at such a pivotal time for the company.
“Our mission at Valo is to accelerate the discovery and development of better medicines for patients by fundamentally changing the traditional discovery paradigm, and I am excited to lead and work with the amazing talent at Valo to deliver meaningful advancements for patients using the power of AI and human-centric data.”
His previous roles include CEO of Foundation Medicine and senior vice-president of research and development and head of Boston Roche Innovation Center for Roche/Genentech.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAt Foundation Medicine, Alexander utilised molecular information to enhance cancer care and clinical decision-making.
Meanwhile, he focused on clinical development at Roche/Genentech, with machine learning, data science, and AI utilisation.
Earlier, he co-founded the Global Coalition for Adaptive Research to expedite treatment discovery and development for rare diseases through clinical trials.
Alexander was also the Harvard/MIT Center for Regulatory Science’s founding director.
At Harvard Medical School, he served as an associate professor and was a radiation oncologist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
Valo and Flagship Pioneering general partner and executive chair Paul Biondi said: “I am delighted to welcome Brian Alexander as the CEO of Valo Health and a Flagship Pioneering CEO-partner.
“Brian’s proven leadership across biotechnology makes him well-positioned to guide Valo into its next chapter of growth, as it harnesses AI-driven technology and high-quality patient data to discover and develop life-changing medicines.”